Novel cationic lipophilic peptides for oligodeoxynucleotide delivery

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 12, 2007, Pages 4091-4097

  Chan, Enoch ^a   Amon, Michael ^b   Marano, Robert J ^c   Wimmer, Norbert ^d   Kearns, Philip S ^d   Manolios, Nicholas ^b   Rakoczy, P Elizabeth ^c   Toth, Istvan ^d  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Lipoamino acids; Modulated T cell function; Oligonucleotide delivery

Indexed keywords

2 AMINODODECANOIC ACID; CYTOFECTIN GSV; GLYCYLLEUCYLARGINYLISOLEUCYLLEUCYLLEUCYLLEUCYLLYSYLVALINE; INTERLEUKIN 2; LAURIC ACID; LIPOPLEX; OLIGODEOXYNUCLEOTIDE; PEPTIDE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CELL ACTIVITY; CELL ASSAY; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; ERYTHROCYTE; GENE TARGETING; GENETIC TRANSFECTION; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOSTIMULATION; ISOTHERMAL TITRATION CALORIMETRY; LIPOPHILICITY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PIGMENT EPITHELIUM; T LYMPHOCYTE ACTIVATION;

BASE SEQUENCE; CACO-2 CELLS; CALORIMETRY; CATIONS; HEMOLYSIS; HUMANS; INTERLEUKIN-2; OLIGONUCLEOTIDES; PEPTIDES; T-LYMPHOCYTES;

EID: 34247602496     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.03.078     Document Type: Article

References (34)

1. Persidis A. Nat. Biotechnol. 17 (1999) 403-404
2. Faria M., Spiller D.G., Dubertret C., Nelson J.S., White M.R., Scherman D., Helene C., and Giovannangeli C. Nat. Biotechnol. 19 (2001) 40-44
3. Yanagihara K., Cheng H., and Cheng P.W. Cancer Gene. Ther. 7 (2000) 59-65
4. Tagawa T., Manvell M., Brown N., Keller M., Perouzel E., Murray K.D., Harbottle R.P., Tecle M., Booy F., Brahimi Horn M.C., Coutelle C., Lemoine N.R., Alton E.W.F.W., and Miller A.D. Gene. Ther. 9 (2002) 564-576
5. Ponimaskin E., Bareesel K.K., Markgraf K., Reszka R., Lehmann K., Gelderblom H.R., Gawaz M., and Schmidt M.F. Virology 269 (2000) 391-403
6. Scott E.S., Wiseman J.W., Evans M.J., and Colledge W.H. J. Gene Med. 3 (2001) 125-134
7. Crystal R.G. Science 270 (1995) 404-410
8. Smith K.T., Shepherd A.J., Boyd J.E., and Lees G.M. Gene Ther. 3 (1996) 190-200
9. Brown M.D., Schatzlein A.G., and Uchegbu I.F. Int. J. Pharm. 229 (2001) 1-21
10. Segura T., and Shea L.D. Ann. Rev. Mater. Res. 31 (2001) 25-46
11. Godbey W.T., and Mikos A.G. J. Control Release 72 (2001) 115-125
12. Pouton C.W., and Seymour L.W. Adv. Drug Delivery Rev. 46 (2001) 187-203 and references cited therein
13. Lee E.R., Marshall J., Siegel C.S., Jiang C., Yew N.S., Nichols M.R., Nietupski J.B., Ziegler R.J., Lane M.B., Wang K.X., Wan N.C., Scheule R.K., Harris D.J., Smith A.E., and Cheng S.H. Hum. Gene Ther. 7 (1996) 1701-1717
14. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., and Bender V. Nat. Med. 3 (1997) 84-88
15. Cameron F.H., Moghaddam M.J., Bender V.J., Whittaker R.G., Mott M., and Lockett T.J. Biochim. Biophys. Acta 1417 (1999) 37-50
16. Gibbons W.A., Hughes R.A., Chralambous M., Szeto A., Aulabaugh A.E.P.M., and Toth I. Liebigs Ann. Chem. (1990) 1175-1183
17. Toth I., Flinn N., Hillery A.M., Gibbons W.A., and Artursson P. Int. J. Pharm. 105 (1994) 241-247
18. Florence, A. T.; Wilderspin, A. F.; Toth, I.; Sakthivel, T.; Bayele, H. K. PCT Int. Appl. 2000, pp. 48, WO 0016807.
19. Garrett K.L., Shen W.Y., and Rakoczy P.E. J. Gene Med. 3 (2001) 373-383
20. Shen, W. Y. Unpublished results, 2002.
21. Akhtar S., Hughes M.D., Khan A., Bibby M., Hussain M., Nawaz Q., Double J., and Sayyed P. Adv. Drug Delivery Rev. 44 (2000) 3-21
22. Rojanasakul Y. Adv. Drug Delivery Rev. 18 (1996) 115-131
23. Garcia Chaumont C., Seksek O., Grzybowska J., Borowski E., and Bolard J. Pharmacol. Ther. 87 (2000) 255-277
24. Helenius A., and Simons K. Biochim. Biophys. Acta 415 (1975) 29-79
25. Azaz E., Segal R., and Milo Goldzweig I. Biochim. Biophys. Acta 646 (1981) 444-449
26. Gould L.A., Lansley A.B., Brown M.B., Forbes B., and Martin G.P. J. Pharm. Pharmacol. 52 (2000) 1203-1209
27. Li Z., Wu W., Kemp O., Stephen M., and Manolios N. Cell Immunol. 190 (1998) 101-111
28. Chantret I., Barbat A., Dussaulx E., Brattain M.G., and Zweibaum A. Cancer Res. 48 (1988) 1936-1942
29. Bachmann A.S., Surovoy A., Jung G., and Moelling K. J. Mol. Med. 76 (1998) 126-132
30. Schnolzer M., Alewood P., Jones A., Alewood D., and Kent S.B. Int. J. Pept. Protein Res. 40 (1992) 180-193
31. Hedrick S.M., Matis L.A., Hecht T.T., Samelson L.E., Longo D.L., Heber Katz E., and Schwartz R.H. Cell 30 (1982) 141-152
32. Kappler J., White J., Wegmann D., Mustain E., and Marrack P. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 3604-3607
33. Shah D.S., Sakthivel T., Toth I., Florence A.T., and Wilderspin A.F. Int. J. Pharm. 208 (2000) 41-48
34. Murphy E.A., Waring A.J., Murphy J.C., Willson R.C., and Longmuir K.J. Nucleic Acids Res. 29 (2001) 3694-3704